SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera

J Infect. 2022 Apr;84(4):e36-e38. doi: 10.1016/j.jinf.2022.02.018. Epub 2022 Feb 19.

Authors

Rima R Sahay¹, Deepak Y Patil¹, Gajanan N Sapkal¹, Gururaj R Deshpande¹, Anita M Shete¹, Dimpal A Nyayanit¹, Sanjay Kumar², Pragya D Yadav³

Affiliations

¹ Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021.
² Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College, Pune, Maharashtra, India, 411040.
³ Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021. Electronic address: hellopragya22@gmail.com.

No abstract available

Keywords: Covishield; Delta; Delta AY.1; Neutralization; SARS-CoV-2; Variant of concern.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Neutralizing
COVID-19*
ChAdOx1 nCoV-19*
Humans
SARS-CoV-2
Spike Glycoprotein, Coronavirus

Substances

Antibodies, Neutralizing
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
ChAdOx1 nCoV-19